首页> 外文期刊>Pharmaceutical research >A comparison of the bioconversion rates and the Caco-2 cell permeation characteristics of coumarin-based cyclic prodrugs and methylester-based linear prodrugs of RGD peptidomimetics.
【24h】

A comparison of the bioconversion rates and the Caco-2 cell permeation characteristics of coumarin-based cyclic prodrugs and methylester-based linear prodrugs of RGD peptidomimetics.

机译:RGD拟肽类的基于香豆素的环状前药和基于甲酯的线性前药的生物转化率和Caco-2细胞渗透特性的比较。

获取原文
获取原文并翻译 | 示例

摘要

PURPOSE: To compare the bioconversion rates in various biological media and the Caco-2 cell permeation characteristics of coumarin based cyclic prodrugs (3a, 3b) and methylester-based linear prodrugs (1b, 2b) of two RGD peptidomimetics (1a, 2a). METHODS: Bioconversion rates of the prodrugs to the RGD peptidomimetics were determined in Hank balances salt solution (HBSS), pH 7,4, at 37 degrees C and in various biological media (human blood plasma, rat liver homogenate, Caco-2 cell homogenate) known to have esterase activity. Transport rates of the prodrugs and the RGD peptidomimetics were determined using Caco-2 cell monolayers, an in vitro cell culture model of the intestinal mucosa. RESULTS. In HBSS, pH 7,4, the coumarin-based cyclic prodrugs 3a and 3b degraded slowly and quantitatively to the RGD peptidomimetics 1a and 2a, respectively (3a, t1/2 = 630+2-14 min; 3b, t1/2 = 301 +/-12 min). The methylester-based linear prodrugs 1b and 2b were more stable to chemical hydrolysis (1b and 2b, t1/2 > 2000 min). Both the coumarin-based cyclic prodrugs and the methylester-based linear prodrugs degraded more rapidly in biological media containing esterase activity (e.g., 90% human blood plasma: 1b, t1/2 < 5 min; 2b, t1/2 < 5 min; 3a, t1/2 < 91+/-1 min; 3b, 1/2 < 57+/-2 min). When the apical (AP)-to-basolateral (BL) permeation characteristics were determined using Caco-2 cell monolayers, it was found that the methylester prodrugs 1b and 2b underwent esterase bioconversion (>80%) to the RGD peptidomimetics 1a and 2a, respectively, In contrast, the cyclic prodrugs 3a and 3b permeated the cell monolayers intact. Considering the appearance of both the prodrug and the RGD peptidomimetic on the BL side, the methylester prodrugs 1b and 2b were approximately 12-fold more able to permeate than were the RGD peptidomimetics 1a and 2a. When similar analysis of the transport data for the coumarin prodrugs 3a and 3b was performed, they were shown to be approximately 6-fold and 5-fold more able to permeate than were the RGD peptidomimetics 1a and 12a, respectively. CONCLUSION: The coumarin-based cyclic prodrugs 3a and 3b were chemically less stable, but metabolically more stable, then the methylester based linear prodrugs. The esterase stability of the cyclic prodrugs 3a and 3b means that they are transported intact across the Caco-2 cell monolayer in contrast to the methylester prodrugs 1b and 2b, which undergo facile bioconversion during their transport to the RGD peptidomimetics. However, both prodrug systems successfully delivered more (5-12-fold) of the RGD peptidomimetic and/or the precursor (prodrug) than did the RGD peptidomimetics themselves.
机译:目的:比较两种RGD拟肽(1a,2a)的基于香豆素的环状前药(3a,3b)和基于甲酯的线性前药(1b,2b)在各种生物介质中的生物转化率和Caco-2细胞的渗透特性。方法:在37℃的汉克天平盐溶液(HBSS),pH 7,4和各种生物介质(人血浆,大鼠肝匀浆,Caco-2细胞匀浆)中测定前药向RGD拟肽的生物转化率。 )已知具有酯酶活性。使用Caco-2细胞单层(肠道粘膜的体外细胞培养模型)确定前药和RGD拟肽的转运速率。结果。在pH 7,4的HBSS中,基于香豆素的环状前药3a和3b分别缓慢定量地降解为RGD拟肽1a和2a(3a,t1 / 2 = 630 + 2-14 min; 3b,t1 / 2 = 301 +/- 12分钟)。基于甲酯的线性前药1b和2b对化学水解更稳定(1b和2b,t1 / 2> 2000分钟)。在含有酯酶活性的生物介质中,基于香豆素的环状前药和基于甲酯的线性前药都降解得更快(例如90%的人类血浆:1b,t1 / 2 <5分钟; 2b,t1 / 2 <5分钟; 3a,t1 / 2 <91 +/- 1分钟; 3b,1/2 <57 +/- 2分钟)。当使用Caco-2细胞单层膜测定了根尖(AP)到基底外侧(BL)的渗透特性时,发现甲酯基前药1b和2b进行了酯酶生物转化(> 80%),转化为RGD拟肽1a和2a,相反,环状前药3a和3b完整地渗透了细胞单层。考虑到前药和RGD拟肽的外观均在BL侧,甲基酯前药1b和2b的渗透能力是RGD拟肽1a和2a的约12倍。当对香豆素前药3a和3b的转运数据进行类似分析时,它们的渗透能力分别比RGD拟肽1a和12a高约6倍和5倍。结论:基于香豆素的环状前药3a和3b在化学上较不稳定,但在代谢上较基于甲酯的线性前药更稳定。环状前药3a和3b的酯酶稳定性意味着它们与Cester-2细胞单层完整运输,而甲基酯前药1b和2b在运输到RGD拟肽过程中容易进行生物转化。然而,与RGD拟肽本身相比,两种前药系统均成功递送了更多(5-12倍)RGD拟肽和/或前体(前药)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号